INtRON Biotechnology (Korea) Market Value
| 048530 Stock | KRW 5,630 20.00 0.36% |
| Symbol | INtRON |
INtRON Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to INtRON Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of INtRON Biotechnology.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in INtRON Biotechnology on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding iNtRON Biotechnology or generate 0.0% return on investment in INtRON Biotechnology over 30 days. INtRON Biotechnology is related to or competes with Medy Tox, Busan Industrial, UNISEM, Finebesteel, Fine Besteel, Hyundai Heavy, and Hanwha Aerospace. iNtRON Biotechnology, Inc., a biotechnology company, develops bacterial bio-drugs for the treatment of infectious diseas... More
INtRON Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure INtRON Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iNtRON Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 10.61 | |||
| Value At Risk | (3.16) | |||
| Potential Upside | 3.5 |
INtRON Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for INtRON Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as INtRON Biotechnology's standard deviation. In reality, there are many statistical measures that can use INtRON Biotechnology historical prices to predict the future INtRON Biotechnology's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (1.11) |
iNtRON Biotechnology Backtested Returns
iNtRON Biotechnology holds Efficiency (Sharpe) Ratio of -0.0691, which attests that the entity had a -0.0691% return per unit of risk over the last 3 months. iNtRON Biotechnology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out INtRON Biotechnology's Standard Deviation of 2.0, risk adjusted performance of (0.08), and Market Risk Adjusted Performance of (1.10) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.21, which attests to not very significant fluctuations relative to the market. As returns on the market increase, INtRON Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding INtRON Biotechnology is expected to be smaller as well. At this point, iNtRON Biotechnology has a negative expected return of -0.13%. Please make sure to check out INtRON Biotechnology's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if iNtRON Biotechnology performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.10 |
Insignificant predictability
iNtRON Biotechnology has insignificant predictability. Overlapping area represents the amount of predictability between INtRON Biotechnology time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iNtRON Biotechnology price movement. The serial correlation of 0.1 indicates that less than 10.0% of current INtRON Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 17.8 K |
iNtRON Biotechnology lagged returns against current returns
Autocorrelation, which is INtRON Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting INtRON Biotechnology's stock expected returns. We can calculate the autocorrelation of INtRON Biotechnology returns to help us make a trade decision. For example, suppose you find that INtRON Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
INtRON Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If INtRON Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if INtRON Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in INtRON Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
INtRON Biotechnology Lagged Returns
When evaluating INtRON Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of INtRON Biotechnology stock have on its future price. INtRON Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, INtRON Biotechnology autocorrelation shows the relationship between INtRON Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in iNtRON Biotechnology.
Regressed Prices |
| Timeline |
Pair Trading with INtRON Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INtRON Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving together with INtRON Stock
Moving against INtRON Stock
The ability to find closely correlated positions to INtRON Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INtRON Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INtRON Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling iNtRON Biotechnology to buy it.
The correlation of INtRON Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INtRON Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if iNtRON Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for INtRON Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in INtRON Stock
INtRON Biotechnology financial ratios help investors to determine whether INtRON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INtRON with respect to the benefits of owning INtRON Biotechnology security.